Blog
1 Effortless Investing Move That Could Nearly Double Your Savings
If you could double your savings without actually investing any additional money out of your own pocket, would you do it?
While taking advantage of this money move may seem like a no-brainer, many
Don't Be Surprised If Roku Soars from Here. Here's Why.
There's little question that streaming video is the wave of the future. The ongoing pandemic has dragged the future kicking and screaming into the present. With accelerating adoption and an agnostic
2 Stocks I Can't Wait to Buy When the Market Crashes Again
In the last stock market crash, shares of Carvana (NYSE: CVNA) and SmileDirectClub (NASDAQ: SDC) were hit exceptionally hard. On March 24, Carvana was down 61% year to date and SmileDirectClub was
Here's Why I Won't Buy Bitcoin, and You Shouldn't, Either
This has been a history-making week, and I'm not just talking about the rollout of coronavirus vaccines. On Wednesday, Dec. 16, we witnessed the largest cryptocurrency in the world by market cap
3 Things to Expect From Peloton in 2021
There's no doubt about it: Connected-fitness company Peloton Interactive (NASDAQ: PTON) was a stock market darling in 2020. As of Dec. 17, the stock is up 371% year to date. The COVID-19 pandemic
How to Claim Up to $2,000 in Free Money for Retirement With the 2021 Saver's Credit
The Saver's Credit, formally known as the Retirement Savings Contribution Credit, is designed to encourage low- to middle-income taxpayers to save for retirement.
We'll get to the qualification
Can Cisco Be a Better Stock Than Zoom Over the Next 5 Years?
Zoom Video Communications (NASDAQ: ZM) has grown revenue at an enormous clip this year, and while it certainly trades for a high valuation, it has proven incredibly profitable. Cisco Systems
Here's Why Opendoor Could Be Such a Great Long-Term Investment
Tech-focused real estate company Opendoor is set to be taken public via SPAC when it merges with blank-check company Social Capital Hedosophia Holdings II (NYSE: IPOB). And if you aren't familiar
This Stock Is Down 10% in 2020, But Investors Who Buy Now Could Enjoy Years of Market-Beating Gains
When people think about e-commerce, usually the first names that come to mind are the big tech giants that we engage with online to shop. And while the technology that underpins online shopping is
3 IRA Mistakes to Avoid in 2021
Independently saving for retirement is important. Without savings of your own, you'll risk falling behind on your bills as a senior -- especially since Social Security won't provide enough income
Is Zillow's New Focus Putting Its Biggest Business at Risk?
Housing has been incredibly strong in 2020, an abnormality during an economic downturn. That's been great for Zillow Group (NASDAQ: Z)(NASDAQ: ZG), one of the most popular online platforms for
If I Could Buy Only 1 Dividend Stock, This Would Be It
Never underestimate the power of dividends. For example, consider the S&P 500 index. Since 2000, it has increased by a little over 150%. But if you include reinvested dividends, the S&P 500's total
2 Warren Buffett Stocks That Will Make You Richer in 2021
Warren Buffett is one of the richest people in the world, and he didn't get there by accident. Unlike other top billionaires, many of whom acquired their wealth through entrepreneurship, Buffett has
Home Depot and Lowe's are Having Huge Years: Can the Growth Continue?
2020 has been a hugely successful year for home improvement retail giants Home Depot (NYSE: HD) and Lowe's (NYSE: LOW). Both have seen revenue and net income grow by double digits as millions of
3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now
I don't use the word "incomparable" very often. That's mainly because most things don't fit the description. It's easy to find comparisons for pretty much everything.
However, I think it's
Who's Ready for Big Social Security Changes in 2021?
The New Year may bring with it big changes. Promising late-stage coronavirus disease 2019 (COVID-19) vaccine results may soon end the pandemic. Meanwhile, President-elect Joe Biden's inauguration on
3 Surefire Growth Stocks to Buy Before 2021
Earlier this year, when the stock market was shaking off its record-setting decline, finding stocks that offered attractive entry points was simple, even for the novice investor. Now, with the major
3 Surprising Stocks We Love For the Housing Boom
Home sales have surged in 2020 thanks to low interest rates and massive pent-up demand from millennials. Even if interest rates creep higher, millennials are the largest demographic group in the
Are No-Cost Mortgage Closings Too Good to Be True?
Image source: Getty Images.
While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full
4 Stocks That Can Triple in a Biden Bull Market
Big changes lie ahead for the U.S. economy. Last week, the first emergency use authorization-approved coronavirus disease 2019 (COVID-19) vaccine was administered to millions of frontline workers
Why I Plan to Buy More of My Top 5 Stocks of 2020
In spite of the odds at the onset of the pandemic in March, I've had plenty of winners -- some of them up triple-digit percentages in 2020. I learned early on in my career that it's often best to
This Was the Best News for Social Security in 2020
More than 60 million Americans count on Social Security benefits right now to help cover their living expenses, and nearly all of us expect to get some money from the program. Yet for years, there
4 Simple Ways Investing Can Double Your Money
Every time you double your money, you have twice as much of it available for your future. If you start investing early enough and aggressively enough, that early money may very well double for you
This Small Cap Advertiser Could Generate Big Gains for Investors
The advertising industry is evolving, with more and more ad dollars moving away from traditional broadcast and cable television and toward connected TV (CTV). Magnite (NASDAQ: MGNI) many not be a
Here's What Investors Should Know About AstraZeneca's COVID Vaccine Data
AstraZeneca (NASDAQ: AZN) published data from its phase 3 clinical trials in The Lancet, but the full data set didn't answer the most important question about why a half-dose followed by a full dose


